{"title":"急性肾损伤中的低剂量急性腹膜透析与急性间歇性血液透析:随机对照试验。","authors":"Watanyu Parapiboon, Sajja Tatiyanupanwong, Kamol Khositrangsikun, Thanawat Phulkerd, Piyanut Kaewdoungtien, Watthikorn Pichitporn, Nuttha Lumlertgul, Sadudee Peerapornratana, Fangyue Chen, Nattachai Srisawat","doi":"10.2215/CJN.0000000000000482","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":50681,"journal":{"name":"Clinical Journal of the American Society of Nephrology","volume":null,"pages":null},"PeriodicalIF":8.5000,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11321733/pdf/","citationCount":"0","resultStr":"{\"title\":\"Lower-Dosage Acute Peritoneal Dialysis versus Acute Intermittent Hemodialysis in Acute Kidney Injury: A Randomized Controlled Trial.\",\"authors\":\"Watanyu Parapiboon, Sajja Tatiyanupanwong, Kamol Khositrangsikun, Thanawat Phulkerd, Piyanut Kaewdoungtien, Watthikorn Pichitporn, Nuttha Lumlertgul, Sadudee Peerapornratana, Fangyue Chen, Nattachai Srisawat\",\"doi\":\"10.2215/CJN.0000000000000482\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":50681,\"journal\":{\"name\":\"Clinical Journal of the American Society of Nephrology\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":8.5000,\"publicationDate\":\"2024-08-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11321733/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Clinical Journal of the American Society of Nephrology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.2215/CJN.0000000000000482\",\"RegionNum\":1,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2024/5/29 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q1\",\"JCRName\":\"UROLOGY & NEPHROLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical Journal of the American Society of Nephrology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.2215/CJN.0000000000000482","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/5/29 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"UROLOGY & NEPHROLOGY","Score":null,"Total":0}
引用次数: 0
摘要
背景:急性腹膜透析(PD)对 AKI 患者的输送剂量较低,需要的资源较少,但却引起了对充分清除溶质和水的担忧。低剂量腹膜透析与间歇性血液透析(HD)的相对优势仍不确定:从 2018 年 5 月到 2021 年 1 月,一项多中心随机对照试验比较了急性低剂量 PD(每天 18-24 升)和间歇性 HD(每周三次)对 AKI 患者的治疗效果。主要结果是 28 天死亡率。次要结果包括 28 天无透析存活率和肾脏恢复、代谢情况和手术相关并发症。如果两组患者 28 天死亡率风险差异(PD-HD)的 95% 置信区间 (CI) 上限小于 20%,则证明 PD 非劣效性优于 HD:我们共纳入了 157 名患者(其中 80 名分配到 PD 组,77 名分配到间歇性 HD 组)。在开始肾脏替代治疗前,两组患者的基线临床特征相当。总平均年龄为 57 ± 15 岁。最常见的 AKI 原因是败血症(68%)。急性透析治疗和间歇性 HD 治疗的 28 天死亡率(50% 对 49%,风险差异为 0.6(95% CI -15.0,16.3))和 28 天无透析生存率(42% 对 37%,风险差异为 4.6(95% CI -11.1,20.3))没有差异。透析组和间歇性 HD 组的每周 Kt/V 尿素平均值分别为 2.11 ± 1.14 和 2.55 ± 1.11。腹膜透析组和间歇性血液透析组患者的 7 天体液平衡无明显差异。间歇性血液透析组出现肾小管内低血压的频率更高,而急性肾功能衰竭组出现低钾血症的频率更高:在这项针对 AKI 患者的研究中,急性局部肾脏缺血和间歇性 HD 患者的 28 天死亡率没有明显差异。
期刊介绍:
The Clinical Journal of the American Society of Nephrology strives to establish itself as the foremost authority in communicating and influencing advances in clinical nephrology by (1) swiftly and effectively disseminating pivotal developments in clinical and translational research in nephrology, encompassing innovations in research methods and care delivery; (2) providing context for these advances in relation to future research directions and patient care; and (3) becoming a key voice on issues with potential implications for the clinical practice of nephrology, particularly within the United States. Original manuscript topics cover a range of areas, including Acid/Base and Electrolyte Disorders, Acute Kidney Injury and ICU Nephrology, Chronic Kidney Disease, Clinical Nephrology, Cystic Kidney Disease, Diabetes and the Kidney, Genetics, Geriatric and Palliative Nephrology, Glomerular and Tubulointerstitial Diseases, Hypertension, Maintenance Dialysis, Mineral Metabolism, Nephrolithiasis, and Transplantation.